心脑通络液治疗心脏神经症（气虚血瘀型）的临床观察

发布时间：2018-12-26 18:26

【摘要】：目的:观察心脑通络液治疗气虚血瘀型心脏神经症患者临床疗效及安全性。方法:选择符合条件的心脏神经症患者共40例。全部患者均来自于黑龙江中医药大学附属第一医院门诊,患者入选后口服心脑通络液20ml,每日3次,疗程28天。记录治疗前后中医症状积分、汉密尔顿焦虑量表(HAMA)及汉密尔顿抑郁量表(HAMD)积分、不良事件等。运用SPSS 19.0统计软件进行结果分析。结果:1.治疗后患者中医症状积分较治疗前下降明显,差异具有统计学意义(P0.01)。2.治疗后患者的汉密尔顿焦虑量表(HAMA)及汉密尔顿抑郁量表(HAMD)积分较治疗前下降明显,差异具有统计学意义(P0.01)。3.治疗过程中患者无明显不良反应。结论:1.心脑通络液能有效降低气虚血瘀型心脏神经症患者中医症状积分,改善心脏神经症患者临床症状。2.心脑通络液能有效降低气虚血瘀型心脏神经症患者汉密尔顿焦虑量表积分及汉密尔顿抑郁量表积分。
[Abstract]:Objective: to observe the clinical efficacy and safety of Xinnao Tongluo liquid in treating cardiac neurosis with qi deficiency and blood stasis. Methods: 40 patients with cardiac neurosis were selected. All the patients were from the first affiliated Hospital of Heilongjiang University of traditional Chinese Medicine. The patients took 20 ml Xinnao Tongluo liquid 3 times a day for 28 days. The scores of TCM symptoms, Hamilton anxiety scale (HAMA) and Hamilton Depression scale (HAMD), adverse events were recorded before and after treatment. The results were analyzed by SPSS 19.0 software. Results: 1. After treatment, the scores of TCM symptoms decreased significantly compared with those before treatment, and the difference was statistically significant (P0.01). The (HAMD) scores of Hamilton anxiety scale (HAMA) and Hamilton Depression scale (HAMD) decreased significantly after treatment (P0.01). There was no significant adverse reaction in the course of treatment. Conclusion: 1. Xinnao Tongluo liquid can effectively reduce the TCM symptom score of patients with Qi-deficiency and blood-stasis type cardiac neurosis, and improve the clinical symptoms of cardiac neurosis patients. 2. Xinnao Tongluo liquid can effectively reduce the scores of Hamilton anxiety scale and Hamilton depression scale in patients with heart neurosis with qi deficiency and blood stasis.
【学位授予单位】：黑龙江中医药大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R277.7

【相似文献】